The improved living and environmental conditions have resulted in an increasein life expectancy with greater observation of breast cancer in elderly. The present study, through aretrospective analysis of our series, compares the results of treatment in two similar groups of patientsunder 75 (65-75) and over 75 (76-85) years of age, evaluating the efficacy and complications of locoregionaland general therapy in relationship to biological age, associated diseases, and also theinfluence on the results of the cultural level and lifestyle.Materials and Methods: The criteria that we evaluated retrospective 110 patients are: age (65-85) with mean age 75, of which 69.8% aged between 65-75 while the remaining 30.2% aged between75-85 years; The TNM, distributed among the patients as: stage I, 5 (4.5%), stage II No 56 (50.9%),stage III No 30 (27.3%) stage IV No. 19 (17.2 %). Associated diseases. Considered in the two groupswere BPCO hypertension, cerebrovascular disease, BMI pathological.Results: Surgical treatment was mastectomy, QUART, lumpectomy. And search for the sentinelnode. The evaluation excluded patients treated on tumorectomy and mastectomy. Complications,shown in Tables 1, have been modest. Perioperative mortality was absent.Discussion: In geriatric patients with breast cancer it is significantly detected as our series. Thisfinding raises the question of what therapeutic strategy should be implemented to overcome the lineof thought that suggests a limited therapeutic treatment, and therefore presumably inadequate TheTNM staging effective to determine the true extent of the disease is essential to avoid a therapeutictreatment is not appropriate, without unnecessary unless a truly effective treatment for elderly patientsConclusions: In the treatment of patients with geriatric breast cancer, TNM cancer criteria wereadopted without removing other as ASA ‘Karnosky Index. This therapeutic approach, beyond old age,considered almost a marginal factor, obtained satisfactory results with a lengthening of life expectancy
Which Surgery in Geriatric Breast Cancer
GRAZIANO, Antonino;
2016-01-01
Abstract
The improved living and environmental conditions have resulted in an increasein life expectancy with greater observation of breast cancer in elderly. The present study, through aretrospective analysis of our series, compares the results of treatment in two similar groups of patientsunder 75 (65-75) and over 75 (76-85) years of age, evaluating the efficacy and complications of locoregionaland general therapy in relationship to biological age, associated diseases, and also theinfluence on the results of the cultural level and lifestyle.Materials and Methods: The criteria that we evaluated retrospective 110 patients are: age (65-85) with mean age 75, of which 69.8% aged between 65-75 while the remaining 30.2% aged between75-85 years; The TNM, distributed among the patients as: stage I, 5 (4.5%), stage II No 56 (50.9%),stage III No 30 (27.3%) stage IV No. 19 (17.2 %). Associated diseases. Considered in the two groupswere BPCO hypertension, cerebrovascular disease, BMI pathological.Results: Surgical treatment was mastectomy, QUART, lumpectomy. And search for the sentinelnode. The evaluation excluded patients treated on tumorectomy and mastectomy. Complications,shown in Tables 1, have been modest. Perioperative mortality was absent.Discussion: In geriatric patients with breast cancer it is significantly detected as our series. Thisfinding raises the question of what therapeutic strategy should be implemented to overcome the lineof thought that suggests a limited therapeutic treatment, and therefore presumably inadequate TheTNM staging effective to determine the true extent of the disease is essential to avoid a therapeutictreatment is not appropriate, without unnecessary unless a truly effective treatment for elderly patientsConclusions: In the treatment of patients with geriatric breast cancer, TNM cancer criteria wereadopted without removing other as ASA ‘Karnosky Index. This therapeutic approach, beyond old age,considered almost a marginal factor, obtained satisfactory results with a lengthening of life expectancyFile | Dimensione | Formato | |
---|---|---|---|
JSSR-2-123-1.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
1.76 MB
Formato
Adobe PDF
|
1.76 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.